Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testogel in older men with partial androgen deficiency of aging
2004-001545-15Phase 4Completed
- Sponsor
- Schering AG
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Hypogonadism comparing Testogel during double-blind period with Placebo during double-blind period (2 arms). Primary endpoint: Change in lean body mass at 6 months. Started Apr 2005; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on 2004-001545-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001545-15.